Rheumatoid arthritis

Cost–utility analysis of longstanding exercise therapy versus usual care in people with rheumatoid arthritis and severe functional limitations

Scand J RheumatolPublished Cost-utility analysis of a randomised controlled trial

Primary result · 1 year societal costsResult — go to the resultDifference 180 € 95% CI €−4493 to €4852

Authors' conclusion

This economic evaluation showed no clear economic preference for either group, as the intervention costs were higher in the intervention group, but partly compensated by other cost savings and improved QALYs.

Study context

Population
Individuals with rheumatoid arthritis (RA) and severe difficulties in performing basic daily activities
Participants
215 individuals
Comparison
Longstanding personalised exercise therapy vs usual care
Primary endpoint
Cost-effectiveness: societal costs and quality-adjusted life-years (QALYs) (EQ-5D-5L and EuroQol Visual Analogue Scale (EQ-VAS))
Follow-up
1 year
Methodological detailseconomic evaluation, 1 year follow-up, cost-effectiveness acceptability curves, Assessments at baseline, 12, 26 and 52 weeks; medical and non-medical costs recorded by patients and healthcare providers
  • Economic evaluation
  • 1 year follow-up
  • Cost-effectiveness acceptability curves
  • Assessments at baseline, 12, 26 and 52 weeks; medical and non-medical costs recorded by patients and healthcare providers

Primary result

1 year societal costs

Difference

180 €

95% CI €−4493 to €4852

Interventionvs Usual care
difference 180 € (95% CI €−4493 to €4852)

As reported in the abstract

Further findings

OutcomeDifference (QALYs) (95% CI)
QALYs (EQ-5D-5L) · 1 yearNon-significantly in favour of intervention0.02 (−0.05 to 0.09)
QALYs (EQ-VAS) · 1 yearNon-significantly in favour of intervention0.04 (0.00–0.08)

Original publication

Cost–utility analysis of longstanding exercise therapy versus usual care in people with rheumatoid arthritis and severe functional limitations. Scand J Rheumatol. Published 1 October 2024. doi:10.1080/03009742.2024.2392360

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.